SPRO
Spero Therapeutics Inc
1.20$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 7,860.6% | 1,660.9% | 854.4% | 1,387.1% | 718.1% | 36.4% | 3.2% | 49.6% | 201.7% | – | |
| – | -7,760.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 50.4% | -101.7% | 100.0% | |
| – | 7,860.6% | 1,660.9% | 854.4% | 1,387.1% | 718.1% | 2,101.8% | 98.0% | 49.6% | 201.7% | 64.5% | |
| – | 2,156.1% | 547.8% | 324.9% | 328.7% | 229.8% | 1,358.3% | 75.1% | 24.1% | 47.8% | 35.5% | |
| – | 10,016.7% | 2,108.6% | 1,079.3% | 1,433.1% | 947.9% | 2,965.5% | 186.9% | 29.7% | 51.2% | 100.0% | |
| – | -9,916.7% | -2,108.6% | -1,079.3% | -1,333.1% | -847.9% | -2,865.5% | -86.9% | 20.7% | -152.9% | 0.0% | |
| – | 0.0% | 15.3% | 7.6% | 0.0% | 0.0% | 63.2% | 5.4% | 0.0% | – | – | |
| – | -9,743.6% | -2,329.3% | -1,050.5% | -1,284.8% | -839.0% | -2,923.6% | -95.5% | 24.5% | -142.9% | 14.8% | |
| – | -2,307.5% | -18.3% | 28.8% | -15.8% | -8.2% | 50.3% | 3.3% | 2.5% | – | 0.4% | |
| – | -7,609.3% | -2,329.3% | -1,050.5% | -1,269.0% | -830.9% | -2,923.6% | -95.5% | 22.0% | -142.9% | 14.4% | |
| – | -9,833.4% | -2,090.3% | -1,069.0% | -1,317.3% | -839.8% | -2,839.4% | -88.4% | 26.2% | -151.1% | 14.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.